首页> 外文会议>International conference on tumor microenvironment >Molecular Profiling in Quiescent and VEGF-activated Human Tumor Derived Vascular Endothelial Cells (HTDEC)
【24h】

Molecular Profiling in Quiescent and VEGF-activated Human Tumor Derived Vascular Endothelial Cells (HTDEC)

机译:静止和VEGF活化人肿瘤衍生的血管内皮细胞(HTDEC)中的分子分析

获取原文

摘要

Endothelial cells (EC) play a significant role in providing and shaping the tumor mi-croenvironment by production and release of regulatory cytokines. To investigate proteins involved in main biological path-ways of HTDEC we performed proteomic analysis of quiescent and VEGF-activat-ed HTDEC. Human umbilical vein endothelial cells (HU-VEC) served as a control. EC where incubated in serum- and growth fac-tor deprived medi-um. After 24hrs, VEGF was added for 6hrs, and ~(35)S-Me-thionine/Cysteine was provided for the last 2hrs. Determination of protein amount by fluorimag-ing of 2D-gels was combined with measurement of incorporated ~(35)S. We found significant differences in the protein synthesis profiles of both quiescent and VEGF activated HUVEC and HTDEC. These differences might result in new targets for antiangiogenic therapies.
机译:内皮细胞(EC)在通过生产和释放调节细胞因子的生产和释放提供和塑造肿瘤MI-Crohens环境方面发挥着重要作用。为了研究参与HTDEC的主要生物路径的蛋白质,我们对静态和VEGF-Activat-ED HTDEC进行了蛋白质组学分析。人的脐静脉内皮细胞(HU-VEC)用作对照。 EC在血清和生长因子植物中孵育的EC剥夺了Medi-um。 24小时后,加入VEGF 6小时,并为最后2小时提供〜(35)〜(35)S-ME-噻嗪/半胱氨酸。通过氟化镁2D-凝胶测定掺入掺入〜(35)的测量的蛋白质量。我们发现静态和VEGF激活HUVEC和HTDEC的蛋白质合成谱的显着差异。这些差异可能导致抗血管生成疗法的新目标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号